VerifiedRx cover art

VerifiedRx

VerifiedRx

By: Vizient Center for Pharmacy Practice Excellence
Listen for free

Summary

 Delivering short doses of insight for hospitals’ frontline pharmacy professionals, the Vizient pharmacy team brings together experts to verify best practices for navigating today’s pharmacy practice challenges and accelerating career growth. It’s a prescription for success, delivered by the Vizient Center for Pharmacy Practice Excellence.Copyright 2025 All rights reserved. Economics Hygiene & Healthy Living Management Management & Leadership Physical Illness & Disease Science
Episodes
  • Beyond Revenue: Measuring Specialty Pharmacy Team Value

    Beyond Revenue: Measuring Specialty Pharmacy Team Value
    May 12 2026

    Defining and documenting pharmacist interventions beyond prescription revenue is essential to demonstrating the full value of pharmacy teams. Host Carolyn Liptak is joined by Dr. Karen Thomas from the University of Illinois Chicago and Dr. Thom Platt from UK Healthcare to share insights from a multi-system survey exploring how interventions are captured and used. They discuss the variability in current practices, the important role of both pharmacists and technicians, and the opportunity to better quantify clinical and operational impact to C-suite.

    Guests:

    Karen C. Thomas, PharmD, PhD, MBA Associate Director, Specialty and Infusion Pharmacies University of Illinois Hospital and Health System

    Thom Platt, PharmD, PhD, MBA ,BCPS Director of Specialty Pharmacy Services UK HealthCare

    Host: 

    Carolyn Liptak, MBA, BS Pharm Pharmacy Executive Director, Regulatory Compliance Vizient Center for Pharmacy Practice Excellence

    Show Notes:

    00:05 – Introduction Overview of VerifiedRx and the focus on pharmacy practice excellence.

    00:14 – Episode Overview & Guest Introductions Host Carolyn Liptak introduces the topic: capturing the value of pharmacist interventions beyond prescription revenue. Guests:

    • Dr. Karen Thomas, University of Illinois Chicago
    • Dr. Thom Platt, UK Healthcare

    00:57 – Health System Backgrounds

    • UIC serves a diverse urban population with a strong Medicaid and Medicare presence
    • UK Healthcare supports patients across Kentucky and surrounding states, including rural populations traveling long distances for specialty care

    01:48 – What Sparked the Research

    • Originated from a Vizient work group focused on outcomes and value
    • Need for clearer frameworks to document and report pharmacist interventions
    • Lack of standardized guidance from accrediting bodies and payers

    02:56 – Survey Goals and Key Findings

    • Explored how health systems define and document interventions
    • Identified major variability in data collection and reporting
    • Found alignment in defining clinical interventions, less consistency in non clinical ones
    • Included responses from 24 health systems

    04:21 – Broader Impact on Pharmacy Practice

    • Reinforces the value of pharmacist contributions beyond revenue
    • Highlights prevention of hospital visits and improved patient outcomes
    • Emphasizes the need to better capture and communicate this value

    05:38 – Applying the Research in Practice

    • UIC developed a structured framework and documentation tool
    • Supports initiatives like waste avoidance studies
    • Aims to quantify cost savings from pharmacist interventions

    06:49 – Relevance Beyond Specialty Pharmacy

    • Concepts apply across all pharmacy settings
    • Data can support staffing, funding, and program expansion decisions
    • Helps communicate value to internal and external stakeholders

    07:52 – Role of Pharmacy Technicians

    • 96 percent of sites report technician involvement in non clinical interventions
    • Examples include resolving medication access issues and addressing social barriers
    • Technicians play a critical role in patient support and care coordination

    09:58 – Future Opportunities

    • Push toward standardizing intervention data collection
    • Opportunity to reduce duplication of effort across health systems
    • Goal to create scalable, shared frameworks

    10:41 – Strategic Value of Intervention Data

    • Supports conversations with leadership and external partners
    • Demonstrates impact on outcomes like reduced ED visits and length of stay
    • Strengthens partnerships with payers and manufacturers

    11:34 – Additional Resources

    • Study published in the Online Journal of Pharmacy
    • Link available for listeners to explore further

    12:03 – Closing Remarks Final thoughts and appreciation for guests Call to action: subscribe, share feedback, and stay engaged with VerifiedRx

    Links and Resources: https://www.mdpi.com/2226-4787/13/6/172

    Subscribe Today!

    Apple Podcasts

    Spotify

    YouTube

    RSS Feed

    Show More Show Less
    13 mins
  • Alpha-gal Syndrome and Impact on Patient Safety

    Alpha-gal Syndrome and Impact on Patient Safety
    Apr 28 2026
    Alpha-gal syndrome is an emerging and often underrecognized allergy triggered by a tick bite that can cause delayed reactions to red meat and mammalian-derived products. In this episode, host Stacy Lauderdale is joined by clinical experts Zack Stacy and Kyna Henrici to unpack the science behind alpha-gal, its implications in healthcare settings, and the operational challenges providers face in managing this complex condition. Guest Speakers: Zachary Stacy, Pharm.D., MS, FCCP, BCPS Clinical Pharmacy Specialist, Surgery BJC Health Kyna Henrici, RN Medical Evidence Director - Cardiovascular Vizient, Inc. Host: Stacy Lauderdale, Pharm.D., BCPS AVP, Evidence-Based Medicine Vizient, Inc. 00:05 – Introduction Podcast introduction and welcome to VerifiedRx 00:14 – What is alpha-gal syndrome Overview of alpha-gal syndrome Delayed allergic reactions after eating red meat Often linked to tick bites 00:48 – Meet the Guests Zack Stacy, clinical pharmacy specialist Kyna Henrici, medical evidence director 01:10 – Understanding the Allergy Alpha-gal is a carbohydrate in nonprimate mammals that can trigger an allergy in humans Key difference is delayed reaction timing Symptoms are not always easy to trace 01:32 – How It Develops Triggered by tick bites Immune system produces IgE antibodies Oral exposure to alpha-gal leads to delayed reactions IV exposure to alpha-gal can cause immediate reactions 02:17 – Prevalence and Diagnosis Challenges More common in Midwest and southern United States Likely underdiagnosed Often mistaken for general food allergies Allergy may fade over time 03:07 – Risks in Healthcare Settings Patient safety concerns beyond food Mammalian components in medications and devices Examples include heparin and surgical materials 03:44 – Hidden Medication Risks Inactive ingredients can be animal derived Examples include glycerin, lactose, amino acids, stearates Difficult to identify and track 04:42 – Lack of Transparency No centralized ingredient database Sourcing can change frequently Variability across manufacturers and batches 05:33 – Screening in Surgical Settings Medication review at NDC level Identification of active and inactive ingredients May require contacting manufacturers 06:45 – Timing Challenges Urgent procedures limit investigation time Manufacturer responses may take days Alternative medications often needed 07:14 – Identifying At Risk Patients Many patients are unaware they have alpha-gal syndrome Screening includes questions about dairy tolerance Three patient categories used for evaluation 08:32 – Using Dairy as a Screening Tool Dairy tolerance helps guide risk level Food exposure typically higher than medication exposure Determines need for deeper review 09:12 – Managing Emergencies Focus shifts from avoidance to risk mitigation Use of team communication and clear documentation Preparation for unavoidable exposure 10:03 – Prevention and Preparedness Stock alpha-gal safe medications when possible Prepare for allergic reactions with standard treatments 10:47 – Team Based Care Approach Collaboration across care teams is essential Premedication strategies may be used Close monitoring for reactions 11:11 – Gaps in Care Limited visibility into product ingredients Need for better labeling and transparency 11:33 – Need for Standardization Call for clearer guidance and clinician education Desire for centralized resource for medication ingredients 12:24 – Monitoring Challenges CDC tracking decreased after privatization of testing Cases likely still increasing 12:53 – Closing Remarks Links and Resources: Alpha-gal Syndrome | Alpha-gal Syndrome | CDC Subscribe Today! Apple Podcasts Spotify YouTube RSS Feed
    Show More Show Less
    14 mins
  • Efficiency to Excellence: AI’s Role in Modern Pharmacy Practice

    Efficiency to Excellence: AI’s Role in Modern Pharmacy Practice
    Apr 14 2026
    AI is rapidly reshaping pharmacy practice, raising both concern and opportunity for healthcare teams. Vizient host Kerry Schwarz is joined by Dr. Jason Chou, Vice President of the System Pharmacy Service Line, and Dr. Catherine Oliver, System AVP of Clinical Pharmacy Services at Ochsner Health, to explore how AI is improving efficiency while redefining how pharmacy teams spend their time. They discuss where technology is already making an impact and where its limits still require human expertise. Guest Speakers: Dr. Jason Chou, Pharm.D., MS Vice President, System Pharmacy Service Line Ochsner Health Dr. Catherine Oliver, Pharm.D., BCPS, DPLA, CPGx System AVP, Clinical Pharmacy Services Ochsner Health Host Dr. Kerry Schwarz, Pharm.D., MPH Senior Clinical Manager, Evidence-Based Medicine and Outcomes Vizient Center for Pharmacy Practice Excellence  Shownotes: 00:05 — Introduction Announcer welcomes listeners to VerifiedRx, produced by the Vizient Center for Pharmacy Practice Excellence. 00:14 — Episode Overview Host Kerry introduces the topic: the role of artificial intelligence (AI) in healthcare and pharmacy.Key themes: Addressing fears of job replacementIdentifying real-world use casesUnderstanding limitations of AIPractical strategies for adoption Guests: Dr. Jason Chou, VP, System Pharmacy Service Line, Ochsner HealthDr. Catherine Oliver, System AVP, Clinical Pharmacy Services, Ochsner Health 01:04 — Will AI Replace Healthcare Jobs? Concern exists, but largely driven by misunderstandingAI is expected to: Augment, not replace, pharmacy rolesImprove efficiency in daily workflows AI is not capable of: Independent clinical judgmentMeaningful patient interactions Human elements—trust, empathy, and nuance—remain essential. 02:20 — Where AI Can Add Value Today Focus should shift from fear to practical use casesIdeal applications: Reducing non-value-added tasksImproving efficiencySupporting clinical decision-making preparation (not replacing it) 02:39 — Early Use Cases: Operational Efficiency AI can reduce administrative burden such as: Prior authorizationsInsurance-related communicationsData gathering and documentation Opportunity to eliminate “busy work” and improve staff satisfaction 03:31 — Clinical Workflow Support AI can: Summarize patient charts, labs, and notesOrganize large volumes of clinical data Enables pharmacists to: Spend less time preparingSpend more time in patient care and provider interaction 04:08 — Additional Opportunities: Supply Chain & Operations AI can support: Inventory managementPurchasing optimizationMulti-site coordination Benefits include: Cost savingsImproved efficiencyBetter resource utilization 05:00 — Where to Draw the Line AI should not replace clinical decision-makingLimitations include: Lack of experience and judgmentInability to incorporate patient values and preferences Final decisions must remain with clinicians. 05:42 — Preserving the Human Element Patient care involves: TrustEmpathyRelationship-building Over-reliance on AI risks eroding patient confidence. 06:11 — Patient Interaction & Transparency Patients want to know: When AI is usedHow it impacts their care Transparency and communication are critical 06:48 — AI in Direct Patient Care: Ambient Listening AI tools can: Capture conversations during patient visitsReduce documentation burden Important considerations: Patient consentAbility to opt outPrivacy concerns 07:31 — Risks of Poor Implementation Poorly designed AI interactions can: Frustrate patientsReduce trust Healthcare AI must avoid: Impersonal experiencesInefficient automation 08:21 — AI as a Tool, Not a Replacement Comparable to tools like: Search engines (e.g., Google) Enhances efficiency without replacing professional roles. 09:12 — Early Success Stories Prior Authorization Optimization AI improves: Data extractionDocumentation speedApproval timelines Benefits: Faster patient access to therapyImproved staff satisfaction 10:07 — Clinical Decision Support Enhancements AI-driven rule systems: Identify high-risk patientsReduce unnecessary chart reviews Example outcome: Reduction in time spent reviewing charts without intervention Frees pharmacists for: Medication reconciliationPatient counseling 11:11 — Impact on Workforce Engagement Staff report: Increased satisfactionMore time for meaningful work AI seen as an enabler rather than a threat 12:03 — Vendor Landscape & Challenges Rapid growth of AI vendors addressing niche problemsKey risks: Data security concernsVendor quality variabilityOverlapping or redundant solutions 12:51 — Integration & Workflow Considerations Successful AI tools must: Integrate with EHRsAlign with pharmacy workflowsAvoid siloed systems Poor integration leads to inefficiency and adoption barriers 14:04 — Vendor Evaluation Considerations Assess: Clinical and operational expertiseProduct maturityImplementation effortRisk vs benefit ...
    Show More Show Less
    17 mins
adbl_web_anon_alc_button_suppression_c
No reviews yet